Scientists develop tomato genetically enriched with Parkinson’s disease drug

News

Author: Johanna Stiefler JohnsonPublished: 17 December 2020

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Researchers in the UK have succeeded in genetically modifying a tomato with a common Parkinson’s disease drug.

As part of the study, the researchers inserted a gene encoding the enzyme tyrosinase into a tomato to elevate levels of the Parkinson’s drug. The aim of this research is to create a more cost-effective production pipeline, wherein the Parkinson’s drug is extracted from enriched tomatoes and purified into the pharmaceutical product. Their findings could positively impact people with Parkinson’s who have restricted access to pharmaceutical drugs, providing a more affordable source of the treatment.

Dr Dario Breitel, the research study’s first author, says: “We have demonstrated that the use of tyrosinase-expressing tomatoes as a source of [the Parkinson’s drug] is possible. It’s a further demonstration of tomato as a strong option for synthetic biology. Additionally, there were surprising beneficial effects including improvement in shelf-life and raised levels of amino-acids that we can investigate.”

Image credit: Phil Robinson, John Innes Centre.


Read more:

A new technique for isolating brain cells linked to Parkinson’s

Diagnosing Parkinson’s disease with “a simple picture of the eye”

Go Back

Share this story

Comments


Related articles


An illustration of a group of people with speech bubbles.

Episodes

How would you answer these three questions on life with Parkinson’s disease?

A very merry podcast special

READ MORE
John McLean

Global update

The life and work of John McLean

A tribute to the artist living with Parkinson’s who died last month

READ MORE
Anne and Mike Mikkelsen

Carers' Corner

Advanced Parkinson’s: a survivor’s guide to ‘transcending the pain of death’

Book review: ‘Love’s Last Measure’ by Anne Mikkelsen

READ MORE